| Authors: |
Rüthrich MM; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin and Berlin Institute of Health, Berlin, Germany. Electronic address: Maria-madeleine.ruethrich@charite.de., Schmitt T; Department of Hematology, and Medical Oncology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; Hamm Hospital Nahetal, Bad Kreuznach, Germany., Classen AY; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF), Braunschweig, Germany., Brandt J; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Spiekermann K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Doleschal AD; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany., Seltmann A; Institute for Diversity Medicine, Medical Faculty, Ruhr-University, Bochum, Germany; Hematology, Oncology and Palliative Care, St. Josef Hospital, Medical Faculty, Ruhr-University, Bochum, Germany; Universitätsklinikum Knappschaftskrankenhaus Bochum-Hämatologie, Onkologie, Stammzelltransplantation und Zelltherapie, Bochum, Germany., Henze L; Department of Medicine, Clinic III-Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, Rostock, Germany; Department of Internal Medicine II, Hematology, Oncology and Palliative Medicine, Asklepios Hospital Harz, Goslar, Germany., Panse J; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany., Sauer G; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany., Schmaedel K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Schalk E; Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany., Vehreschild MJGT; Department II of Internal Medicine, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt am Main, Germany., Vehreschild JJ; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany; Department II of Internal Medicine, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt am Main, Germany., Teschner D; Department of Hematology, and Medical Oncology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., von Lilienfeld-Toal M; Institute for Diversity Medicine, Medical Faculty, Ruhr-University, Bochum, Germany; Hematology, Oncology and Palliative Care, St. Josef Hospital, Medical Faculty, Ruhr-University, Bochum, Germany; Universitätsklinikum Knappschaftskrankenhaus Bochum-Hämatologie, Onkologie, Stammzelltransplantation und Zelltherapie, Bochum, Germany., Giesen N; Department for Hematology, Oncology and Palliative Care, Robert Bosch Hospital, Stuttgart, Germany; Robert Bosch Center for Tumor Diseases, Stuttgart, Germany. |
